In Cloning, Will One Person Really Make a Difference?

In just a week, two developments in Washington restored cloning to the very top of the policy agenda in the United States, knocking stem cell research off the perch it had enjoyed--or just endured--for months. On July 31, by a vote of 265 to 162, the House of Representatives passed the Human Cloning Prohibition Act of 2001, a ban on all human cloning, including therapeutic cloning to derive immunologically compatible embryonic stem cells. And on August 7, Severino Antinori, an infertility specia

Arlene Judith Klotzko
Aug 19, 2001
In just a week, two developments in Washington restored cloning to the very top of the policy agenda in the United States, knocking stem cell research off the perch it had enjoyed--or just endured--for months. On July 31, by a vote of 265 to 162, the House of Representatives passed the Human Cloning Prohibition Act of 2001, a ban on all human cloning, including therapeutic cloning to derive immunologically compatible embryonic stem cells. And on August 7, Severino Antinori, an infertility specialist from Rome, announced he was going to clone a human by November. It seems as if an awful lot of people want to be cloned. Out of the many who applied, two hundred couples were selected. They made their way to a clinic in Rome from all over the world--Japan, Britain, and the United States included. Antinori's patients are infertile men. Because of accident or disease, they cannot...

Interested in reading more?

Become a Member of

Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member?